University Hospital Reina Sofía

Córdoba 14005

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Prostate Cancer

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Telomere Associated Variables (TAVs) in Prostate Cancer — Completed